FibroGen
FGEN
FGEN
208 hedge funds and large institutions have $2.84B invested in FibroGen in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 72 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.03% more ownership
Funds ownership: 3.02% → 3.05% (+0.03%)
8% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 72
38% less call options, than puts
Call options by funds: $18.8M | Put options by funds: $30.5M
Holders
208
Holding in Top 10
2
Calls
$18.8M
Puts
$30.5M
Top Buyers
| 1 | +$65.9M | |
| 2 | +$15.8M | |
| 3 | +$13.6M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$9.59M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$9.25M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$17.1M | |
| 3 | -$14.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$12.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.9M |